SCHEMBL26007359

SCHEMBL26007359

CN1CCN(C(=O)C2COC2)CC1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.56
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PPP5C P53041 2/20 0.46
PPP2CA P67775 1/20 0.46
TFPI2 P48307 1/20 0.46
NPY4R P50391 1/20 0.46
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
HSD11B1 P28845 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KMT2A Q03164 1/20 0.38
HTR1A P08908 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21584689 0.85 HTT (0.54) HTTLMNACYP1A2TDP1PPP5C
SCHEMBL25629645 0.85 HTT (0.54) HTTLMNACYP1A2TDP1PPP5C
SCHEMBL26615179 0.80 HPGD (0.60) HTTLMNATFPI2TSHRALDH1A1
SCHEMBL2075903 0.80 HTT (0.81) HTTLMNACYP1A2TDP1PPP5C
SCHEMBL4036894 0.80 HTT (0.62) HTTLMNAPPP5CPPP2CATFPI2
SCHEMBL25629007 0.79 HRH3 (0.51) TSHRALDH1A1HRH3
SCHEMBL30072403 0.78 HPGD (0.64) HTTLMNATSHRALDH1A1HSD11B1
SCHEMBL16838101 0.78 HTT (0.60) HTTLMNACYP1A2TDP1PPP5C
SCHEMBL8194135 0.78 HTT (0.71) HTTLMNACYP1A2TDP1PPP5C
SCHEMBL25811260 0.78 ALDH1A1 (0.46) HTTTSHRALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023121413-A1 NOVEL BICYCLIC HETEROCYCLYL COMPOUND AND USE THEREOF 제일약품주식회사 2023-06-29 WO disclosed
WO-2023093832-A1 TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海济煜医药科技有限公司 2023-06-01 WO disclosed